1. Tumor Immunology, University Cancer Center (UCC), ‘Carl Gustav Carus,’ TU Dresden, Dresden, Germany
2. Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany
3. Institute of Immunology, ‘Carl Gustav Carus’, TU Dresden, Dresden, Germany
4. GEMoaB Monoclonals GmbH, Dresden, Germany
5. Cellex Patient Treatment GmbH, Dresden, Germany
6. Medical Clinic and Policlinic I, University Hospital ‘Carl Gustav Carus’, TU Dresden, Dresden, Germany
7. German Cancer Consortium (DKTK), partner site Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany
8. National Center for Tumor Diseases (NCT), ‘Carl Gustav Carus,’ TU Dresden, Dresden, Germany
9. Department of Chemistry and Food Chemistry, School of Science, TU Dresden, Dresden, Germany